These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic value of total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with uterine carcinosarcoma. Lee JW, Heo EJ, Moon SH, Lee H, Cheon GJ, Lee M, Kim HS, Chung HH. Eur Radiol; 2016 Nov; 26(11):4148-4154. PubMed ID: 26883331 [Abstract] [Full Text] [Related]
4. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH, Kang SM, Jeong SY, Lee SW, Lee SJ, Lee J, Ahn BC. Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [Abstract] [Full Text] [Related]
6. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY, Guo Z, Sun J, Yang WP, Li TR. Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362 [Abstract] [Full Text] [Related]
8. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma]. Wu LL, Liang JH, Wang L, Xu W, Ding CY. Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):831-836. PubMed ID: 31770850 [Abstract] [Full Text] [Related]
9. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH, Chiu NT, Su WC, Guo HR, Lee BF. Radiology; 2012 Aug 23; 264(2):559-66. PubMed ID: 22692034 [Abstract] [Full Text] [Related]
10. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y, Lu P, Yu L. Acad Radiol; 2016 May 23; 23(5):605-10. PubMed ID: 26853968 [Abstract] [Full Text] [Related]
13. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS. Medicine (Baltimore); 2016 May 23; 95(19):e3686. PubMed ID: 27175707 [Abstract] [Full Text] [Related]
15. Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer. Krhili S, Muratet JP, Roche S, Pointreau Y, Yossi S, Septans AL, Denis F. Am J Clin Oncol; 2017 Jun 23; 40(3):250-255. PubMed ID: 27028351 [Abstract] [Full Text] [Related]
16. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. J Nucl Med; 2013 Jul 23; 54(7):1032-8. PubMed ID: 23670902 [Abstract] [Full Text] [Related]
19. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy. Sharma A, Mohan A, Bhalla AS, Sharma MC, Vishnubhatla S, Das CJ, Pandey AK, Sekhar Bal C, Patel CD, Sharma P, Agarwal KK, Kumar R. Clin Nucl Med; 2018 Jan 23; 43(1):e8-e17. PubMed ID: 29112011 [Abstract] [Full Text] [Related]
20. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer. Qu YH, Long N, Ran C, Sun J. Clin Transl Oncol; 2021 Mar 23; 23(3):620-627. PubMed ID: 32683540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]